Advertiment
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
Rigolin GM, Maffei R, Rizzotto L, Ciccone M, Sofritti O, Daghia G, Cibien F, Cavazzini F, Marasca R, Cuneo A.
Hematology Section, St. Anna University Hospital, University of Ferrara, Ferrara, Italy.
BACKGROUND:: In patients with cancer, circulating endothelial cells (CECs) are increased and are correlated with an aggressive disease course. However, the clinical and biologic significance of CECs in chronic lymphocytic leukemia (CLL) remains uncertain. METHODS:: In 170 patients with CLL, CEC levels were quantified by flow cytometry and were correlated with clinical and biologic data. In addition, CECs were characterized by immunophenotypic, fluorescence in situ hybridization (FISH), and gene expression profile analyses. RESULTS:: In patients with CLL, CECs were increased compared with controls. A higher level of CECs (>20/muL) identified a subset of patients with a more aggressive disease course characterized by a shorter time to first treatment both in univariate and multivariate analyses. In FISH analysis, 7 patients had a significant proportion of CECs and presented with the same cytogenetic lesion of neoplastic lymphocytes and immunophenotypic features of endothelial progenitor cells. The gene expression profile of sorted CECs revealed a molecular pattern, suggesting a derivation from CLL leukemic cells with increased cell survival and proliferation, diminished cell adhesion to extracellular matrix, and enhanced proangiogenic function compared with their normal counterparts. CONCLUSIONS:: The current data suggest that, in CLL, CECs may represent a biologic marker of aggressiveness and disease progression to be considered for new, targeted antiangiogenic treatments. Cancer 2010. (c) 2010 American Cancer Society.
Related Search
CURRENT CIRCULATI,
Leave a Reply
Suggested Posts
Potential New Treatment For Kidney Cancer By Specific Inhibition Of Autophagy Circulati g e dothelial cells i patie ts with chro ic lymphocytic leukemia: cli ical-prog ostic a d biologic sig ifica ce. Rigoli GM, Maffei R, Rizzotto L, Cicco e M, Sofritti O, Daghia G, Cibie F, Cavazzi i F, Marasca R, Cu eo A. Hematology Sectio , St. A a U iversity Hospital, U iversity of Ferrara, Ferrara, Italy. BACKGROUND:: I patie ts with ca cer, circulati g e dothelial cells (CECs) are i creased [...]. Posted February 20th, 2010 | 3:34 pm
Treatment Of Gynecologic Cancers Reduced From 5 Weeks To 3 Days Using New Radiation Therapy Circulati g e dothelial cells i patie ts with chro ic lymphocytic leukemia: cli ical-prog ostic a d biologic sig ifica ce. Rigoli GM, Maffei R, Rizzotto L, Cicco e M, Sofritti O, Daghia G, Cibie F, Cavazzi i F, Marasca R, Cu eo A. Hematology Sectio , St. A a U iversity Hospital, U iversity of Ferrara, Ferrara, Italy. BACKGROUND:: I patie ts with ca cer, circulati g e dothelial cells (CECs) are i creased [...]. Posted February 20th, 2010 | 3:34 pm
Joint Clinical Practice Guidelines On Hepatocellular Carcinoma Management To Be Published By EASL-EORTC Circulati g e dothelial cells i patie ts with chro ic lymphocytic leukemia: cli ical-prog ostic a d biologic sig ifica ce. Rigoli GM, Maffei R, Rizzotto L, Cicco e M, Sofritti O, Daghia G, Cibie F, Cavazzi i F, Marasca R, Cu eo A. Hematology Sectio , St. A a U iversity Hospital, U iversity of Ferrara, Ferrara, Italy. BACKGROUND:: I patie ts with ca cer, circulati g e dothelial cells (CECs) are i creased [...]. Posted February 20th, 2010 | 3:34 pm
Potential Strategy Aims To Stimulate The Immune System To Defeat Cancers Circulati g e dothelial cells i patie ts with chro ic lymphocytic leukemia: cli ical-prog ostic a d biologic sig ifica ce. Rigoli GM, Maffei R, Rizzotto L, Cicco e M, Sofritti O, Daghia G, Cibie F, Cavazzi i F, Marasca R, Cu eo A. Hematology Sectio , St. A a U iversity Hospital, U iversity of Ferrara, Ferrara, Italy. BACKGROUND:: I patie ts with ca cer, circulati g e dothelial cells (CECs) are i creased [...]. Posted February 20th, 2010 | 3:34 pm
Roche medicine Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer Circulati g e dothelial cells i patie ts with chro ic lymphocytic leukemia: cli ical-prog ostic a d biologic sig ifica ce. Rigoli GM, Maffei R, Rizzotto L, Cicco e M, Sofritti O, Daghia G, Cibie F, Cavazzi i F, Marasca R, Cu eo A. Hematology Sectio , St. A a U iversity Hospital, U iversity of Ferrara, Ferrara, Italy. BACKGROUND:: I patie ts with ca cer, circulati g e dothelial cells (CECs) are i creased [...]. Posted February 20th, 2010 | 3:34 pm